Lassogen
Pre-clinicalLassogen is developing a new therapeutic modality based on lasso peptides that we are programming to treat difficult diseases such as cancer and autoimmune ...
Founded
2016
Focus
RNA & Gene Therapy
About
Lassogen is developing a new therapeutic modality based on lasso peptides that we are programming to treat difficult diseases such as cancer and autoimmune ...
Funding History
2Total raised: $18.5M
Series A$15MUndisclosedFeb 15, 2023
Seed$3.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile